OUR THERAPIES

Giving patients a chance, providing hope, is what drives us

OUR APPROVED THERAPIES

Filspari.com

Filspari Prescribing Info

Filspari Medication Guide

FispariRems.com

TravereTotalCare.com or call 833-345-7727

thiolaEC.com

Thiola EC Prescribing Info

Thiola Prescribing Info

Thiola EC Total Care Hub or call 844-484-4652

On September 5, 2023, Travere Therapeutics announced that Mirum Pharmaceuticals acquired all of Travere’s rights and assets related to Cholbam^® and Chenodal^®. For more information please visit mirumpharma.com.

Cholbam.com

Cholbam Prescribing Info

Cholbam Total Care Hub or call 844-246-5226

Chenodal Prescribing Info

Chenodal Total Care Hub information or call 844-246-5226

Comprehensive Patient Support

Travere Therapeutics has established a comprehensive patient support program to enable a smooth experience for patients, their caregivers and healthcare providers. This program provides services, assistance and resources to help patients understand their diagnosis, manage the insurance process, fill their prescriptions, and initiate treatment. Use the links above for Travere TotalCare and Total Care Hub to access these services for each therapy.

OUR THERAPIES

OUR APPROVED THERAPIES

On September 5, 2023, Travere Therapeutics announced that Mirum Pharmaceuticals acquired all of Travere’s rights and assets related to Cholbam® and Chenodal®. For more information please visit mirumpharma.com.

Comprehensive Patient Support

On September 5, 2023, Travere Therapeutics announced that Mirum Pharmaceuticals acquired all of Travere’s rights and assets related to Cholbam^® and Chenodal^®. For more information please visit mirumpharma.com.